NovaBay Pharmaceuticals Inc. (NBY) Slipped -6.25% or -0.2 To Price $3.0 On Monday


NovaBay Pharmaceuticals Inc. (NBY) slipped -6.25% or -0.2 to $3.0. It is near to 27027 shares traded, which is 286.42% compare to the average total volume 9436. The market cap of NBY is $51.25 million. The year to date change is -21.95%. The 52 week price range is from $2.25 to $5.0. Price of NBY have changed -6.63% during last week. It have changed -9.09% over last month, -22.89% over last 3 months, -24.71% over last 6 months and -20.00% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for NBY is 3.58. It is 19.33% above current price. The 200-day Moving Averages for NBY is 3.88. It is 29.33% above current price. The 52-week High is 5.0. It is 66.67% from the current price. The 52-week Low is 2.25. It is -25.00% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of NBY is 11.68 on 2018-02-15. Short % to float is 0.89%. There are some statistics of NBY. It is has market cap $51.25 million. The share outstanding is 17.08 million. The average volume is 9436. The revenue is 15.99M. The gross profit is 13.38M. The percent of top 15 Institution holding is 0.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of NBY is -230.27%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of NBY is -75.15%.


Tags:

Share this post